{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Understanding ACS patient– Presentation, Treatment goals and Management (APTeM Study)

Questionnaire
  1. In your patients post ACS – what is the LDL (mg/dL) goal that you prefer to target *

  2. What percentage of your ACS patients are *
    3. Male
    %
    Female
    %
    Others
    %
  3. What percentage of your ACS patients are on high intensity statin? *

  4. Despite high intensity statin therapy what percentage of your ACS patients continue to have high LDL levels *

  5. In patients of ACS having high LDL despite high intensity statin, what is the management in your clinical practice? *
  6. In patients of ACS receiving with high LDL despite high intensity statin, what is the usage of following therapies (please provide percentages) *

  7. What % of patients are receiving following therapies? *
    8. Evolocumab
    %
    Inclisiran
    %
  8. Please provide patient profiles in whom Evolocumab or Inclisiran are preferred? *
  9. What is the additional LDL lowering you are able to achieve by adding the following therapies to statin? (please provide reduction in %) *
    10. Ezetimibe
    %
    Combination of Ezetimibe + Bempedoic Acid
    %
    Bempedoic acid alone
    %
  10. In your clinical practice, have you administered triple combination of statin + Ezetimibe and Bempedoic acid? *

  11. If yes, the please provide the patient profiles in whom you will administer triple combination of statin + Ezetimibe and Bempedoic acid?
  12. How long do you administer with following therapies along with statin in your patients with ACS? *
    13. Ezetimibe
    Combination of Ezetimibe + Bempedoic Acid
    Bempedoic acid alone
    Evolocumab
    Inclisiran
  13. If triglycerides levels are high in ACS patients, kindly provide management plan in your clinical practice?
  14. In how many patients do you recommend hsCRP testing per month in your practice? *

  15. Do you recommend CAC (coronary artery calcium) scoring in your patients? *

  16. If yes for CAC scoring then in how many patients do you recommend CAC scoring test in your practice?

  17. Kindly provide the patient profiles in whom CAC scoring can be recommended? *
  18. What is your opinion regarding positive correlation between CAC scoring and ASCVD risk scoring? *

  19. In how many patients do you recommend ApoB in your clinical practice? *

  20. Kindly provide the patient profiles in whom ApoB testing can be recommended? *
  21. In your high-risk patients with high LDL despite statin therapy, have you prescribed? *
    22. Evolocumab

    Inclisiran

  22. No of patients on Evolocumab in your clinical practice? *

  23. If patients are on evolocumab then how long do you administer it in your clinical practice?

  24. No of patients on Inclisiran in your clinical practice? *

  25. Based on your experience what is the expected adherence to Inclisiran in ACS patients in your clinical practice? *

  26. In your practice what % of patients experience recurrent ACS within 3 months *

  27. Please provide distribution of patients presenting with ACS according to the age in your clinical practice? *
    28. <40 years
    % patients
    40-50 years
    % patients
    50-60 years
    % patients
    >60 years
    % patients
  28. What is % of men and women diagnosed with ACS in your clinical practice? *
    29. Male
    %
    Female
    %
    Others
    %
  29. In case of early onset of risk factors like hypertension, diabetes, obesity, high cholesterol is there a gender difference? If yes, please provide details *

  30. What % of ACS patients progress to *
    31. Heart Failure
    % patients
    Atrial Fibrillation
    % patients
    Recurrent MI
    % patients
  31. Which high dose statin do you prefer in your ACS patients? (choose any 2) *

  32. What is the most important reason to choose high intensity statin (choose any 2) *

  33. In your ACS patients which of the following are applicable? *

    34. For Treatment compliance

  34. In your ACS patients which of the following are applicable? *

    35. For Follow up visits

  35. In your ACS patients which of the following are applicable? *

    36. For Life style interventions